[ad_1] Cantor Fitzgerald initiated coverage on Sorrento Therapeutics Inc (NASDAQ: SRNE) with an Overweight rating and a price target of $5. The analyst…
Read More »potential
[ad_1] A Jet2 flight which had taken off in turkey and was making its way to Manchester was diverted to…
Read More »[ad_1] It can be maddening when other people don’t see the world the way we do. In the stock market,…
Read More »